Edding Genor Renames Group and Changes Hong Kong Stock Short Name

Genor Biopharma Holdings Limited ( (HK:6998) ) has provided an update.

Edding Genor Group Holdings Limited has officially changed its corporate name from Genor Biopharma Holdings Limited to Edding Genor Group Holdings Limited, with a corresponding change to its dual foreign Chinese name, following shareholder approval and registration in both the Cayman Islands and Hong Kong. In line with this rebranding and to reflect the business of the enlarged group and its relationship with controlling shareholders after the merger, the company’s stock short name on the Hong Kong Stock Exchange will change to “EDDING GENOR” in English and a new Chinese short name from 6 February 2026, while its stock code 6998 and shareholders’ rights remain unchanged, signalling continuity of listing status alongside an updated group identity.

The most recent analyst rating on (HK:6998) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Genor Biopharma Holdings Limited stock, see the HK:6998 Stock Forecast page.

More about Genor Biopharma Holdings Limited

Edding Genor Group Holdings Limited, formerly known as Genor Biopharma Holdings Limited, is a Cayman Islands–incorporated company listed on the Main Board of the Hong Kong Stock Exchange. The group operates in the biopharmaceutical sector and has recently undergone a merger that created an enlarged group structure and strengthened ties with its controlling shareholders.

Average Trading Volume: 1,130,295

Technical Sentiment Signal: Sell

Current Market Cap: HK$5.02B

See more insights into 6998 stock on TipRanks’ Stock Analysis page.